Trials / Completed
CompletedNCT03104478
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 219 (actual)
- Sponsor
- The Lymphoma Academic Research Organisation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The trial will enroll 194 previously untreated DLBCL patients over 20 months, with the objective to send to the local investigator an extensive molecular tumor characterization by D38 in at least 80% of enrolled patients. The feasibility and efficiency will be demonstrated by deploying and operating a nation-wide network of dedicated multidisciplinary platforms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biological samples collection | In addition to collection and characterization of tumor biopsy samples done for diagnosis (standard care), collection of blood samples at study entry for further biological analyses. |
Timeline
- Start date
- 2017-05-09
- Primary completion
- 2019-10-11
- Completion
- 2021-09-04
- First posted
- 2017-04-07
- Last updated
- 2021-12-07
Locations
15 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03104478. Inclusion in this directory is not an endorsement.